Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant <i>Klebsiella pneumoniae</i>-Reference-Cited by-同舟云学术

Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae

Published:2023-09-05 Issue:10 Volume:9 Page:1858-1866
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Shi Shiyi¹,Xu Mengxin²,Zhao Yining²,Feng Luozhu¹,Liu Qi²,Yao Zhuocheng¹,Sun Yao²,Zhou Tieli²^ORCID,Ye Jianzhong²^ORCID

Affiliation:

1. Department of Medical Laboratory Science, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, People’s Republic of China

2. Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou 325000, People’s Republic of China

Funder

National Natural Science Foundation of China

Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.3c00186

Reference53 articles.

1. Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection

2. Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods

3. Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art

4. Antimicrobial resistance surveillance in Europe 2023 - 2021 data. European Centre for Disease Prevention and Control and World Health Organization; Stockholm, 2023 https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2023-2021-data.

5. Status report on carbapenemases: challenges and prospects